Therefore, the results of the present study not only showed the value of the 13-gene signature as a promising classification tool for COAD prognosis but also provided new insights into the role of NAT1 and NAT2 in the tumorigenesis and progression of COAD. Here, NAT2 is linked to colon adenocarcinoma.